Announcements Trials
Browse Landscape

Phase

Phase 1 114Phase 2 72Phase 1/2 62Phase 3 20Phase EARLY_PHASE1 13Phase NA 5Phase 2/3 3Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 5INDUSTRY 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Thoracic 1Gynecologic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 27Neoplasms 22Breast Neoplasms 20Neoplasm Metastasis 18Colorectal Neoplasms 16Stomach Neoplasms 15Recurrence 15Prostatic Neoplasms 15Carcinoma, Hepatocellular 12Pancreatic Neoplasms 11Ovarian Neoplasms 11Head and Neck Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Lung Neoplasms 10Myasthenia Gravis 9Melanoma 9Leukemia, Myeloid, Acute 9Urinary Bladder Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Liver Neoplasms 6Cholangiocarcinoma 6Carcinoma, Transitional Cell 6Triple Negative Breast Neoplasms 5Small Cell Lung Carcinoma 5Lymphoma, Follicular 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia 5

Interventions

anlotinib 1Radiotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × INDUSTRY × Sarcoma × Clear all
NCT02379845 2021-04-06

NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Nanobiotix

Phase 2/3 Completed
180 enrolled
Sarcoma

Sarcoma

NCT02449343 2017-04-25

Study of Anlotinib in Patients With Soft Tissue Sarcoma(STS)(ALTER0203)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2/3 Unknown
233 enrolled
Sarcoma

Sarcoma

NCT00243685 2012-01-26

Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis

Pierian Biosciences

Phase 2/3 Completed
150 enrolled
BreastGynecologicSarcomaThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡